Korean company Medison, best known as a maker of high-quality ultrasound equipment, will soon file for court receivership, according to Asian news services. The company is laboring
Korean company Medison, best known as a maker of high-quality ultrasound equipment, will soon file for court receivership, according to Asian news services. The company is laboring under a huge debt, reported Asia Pulse, and can no longer service its loans. Medison holds 247.2 billion won (US$185.4 million) in interest-bearing debt and has short-term liabilities maturing in 2003 exceeding 175 billion won (US$131.25 million). Company executives contacted creditors Jan. 29 about their decision to file for bankruptcy after missing a 4.4 billion won (US$3.3 million) loan payment, according to the Korea Times.
Founded in 1985, Medison quickly became an international icon for Korean prosperity, capturing a majority of the Korean marketplace for ultrasound and forging deals with international vendors to supply low-cost ultrasound equipment. The company also was a major promoter of real-time 3D ultrasound systems. Its demise appears to be due primarily to ill-considered ventures in Web-based businesses. The plunge in stock prices of companies in which Medison had invested borrowed funds began to destabilize the company more than a year ago, according to Asia Pulse. Medison posted 116 billion won in net losses in 2000 compared with 52.3 billion won in net profits the previous year. In a bid to remain solvent, Medison has been selling assets. Among these was its share in Kretztechnik, which GE purchased in October (SCAN 10/17/01). A statement released by Medison and its creditors, reported by Asia Pulse, said company executives are seeking corporate alliances and foreign investments.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).